publication date: Nov. 5, 2010

In this issue:


NLST Shows 20.3 Percent Mortality Benefit For CT Vs. X-Ray In Lung Cancer Screening  Duke Retraction May Alter IOM Investigation; 

Review Panel Membership Announced 

Tighter Payment Policy 

For ADT Reduced Use


McKesson To Purchase US Oncology Afinitor Approved for Rare Disorder Sprycell Approved for CML Download PDF


To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.